CV today
$6.27-$0.10 (-1.57%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourBearish
15 minExpanding
5 minDescending Triangle
Daily trend turns up above $36.36
Key levels
Resistance$7.23
Resistance$6.81
Support$6.12
Support$5.75
Latest news & SEC filings
EarningsCapsoVision to report Q3 2026 numbers on November 12, 2026
ProductCapsoVision wins FDA clearance for AI reading tool on CapsoCam Plus
All CV news →About CapsoVision
CapsoVision is a medical technology company that makes capsule endoscopy products for spotting and screening abnormalities in the digestive tract. Its main offering is CapsoCam Plus, a single-use capsule that captures a 360-degree panoramic view for examining the small intestine in both adults and children, along with cloud-based CapsoCloud and CapsoView software for reviewing the video. The company sells to gastroenterologists working in clinics and hospitals, mainly through its own sales force in the United States and a combination of direct sales and distributors abroad. It is also developing CapsoCam Colon for detecting and measuring colon polyps.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
CapsoVision, Inc (CV)
What Is the Price Target for CV?
SEPT Low Target
$8.50
SEPT Mid Target
$10.00
SEPT High Target
$11.50
Analyst Consensus
$10.00
Is CV a Buy or Sell Right Now?
Thesis
- •Revenue growing 15.3% YoY with STRONG trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CV.
Start Free Trial →Is CV Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$10.00
38
Moat Score
NONE
2/9
Piotroski Score
5.2
Altman Z-Score
What Is Smart Money Doing with CV?
Insider Signal
BUYING
4 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
UNCHANGED
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| HARARI ELIYAHOU ET AL | 10% owner | Buy | 878,735 | $5.0M | Sep 18, 2026 |
| HARARI ELIYAHOU ET AL | 10% owner | Buy | 878,734 | $5.0M | Sep 18, 2026 |
| Shen Ching Hang | 10% owner | Buy | 878,734 | $5.0M | Sep 15, 2026 |
| Shen Ching Hang | 10% owner | Sale | 3,991,606 | - | Apr 17, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CV Growth Story
Revenue YoY
15.3%
3yr Revenue CAGR
N/A%
EPS Growth YoY
89.54%
FCF Growth YoY
-13.4%
Revenue Trend
STRONG
Dark Pool Trades for CV
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CV, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:26:05 | $6.27 | 2,351 | $$15K | SELL |
| 21:00:27 | $6.37 | 3,019 | $$19K | BUY |
| 21:00:27 | $6.37 | 1,581 | $$10K | BUY |
| 21:00:00 | $6.37 | 17,281 | $$110K | MIDPOINT |
| 20:59:06 | $6.39 | 1,266 | $$8K | SELL |
5 dark pool trades shown · $$162K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CapsoVision, Inc (CV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CV — frequently asked questions
What is CV stock price today?
CapsoVision, Inc (CV) is at $6.27, down 1.57% (-$0.10) at the Nov 11, 2026 close.
Why is CV stock moving today?
Latest CV news — Oct 30, 2026: CapsoVision to report Q3 2026 numbers on November 12, 2026 · Sep 28, 2026: CapsoVision wins FDA clearance for AI reading tool on CapsoCam Plus
What is the CV price target?
The average analyst price target for CV is $10.00, ranging from $10 to $10, based on 1 analysts. Latest: Benchmark maintains on Mar 27, 2026.
What do analysts rate CV?
Analyst ratings for CV: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did CV beat earnings?
CV last reported on Aug 13, 2026: EPS -$0.15 vs -$0.13 expected — a miss of 15.4%.
What is CV's P/E ratio?
CV trades at a P/E of 2.2 vs a Healthcare average of 17.9.
Does CV pay a dividend?
CV does not currently pay a dividend.
What are CV support and resistance levels?
Support: $6.12, $5.75, $5.36. Resistance: $6.81, $7.23, $7.77.
What are insiders doing with CV?
Insider activity: BUYING, 4 buys and 0 sells in the last 90 days.
What is the latest news on CV?
Oct 30, 2026: CapsoVision to report Q3 2026 numbers on November 12, 2026 · Sep 28, 2026: CapsoVision wins FDA clearance for AI reading tool on CapsoCam Plus